TENX
Price:
$11.48
Market Cap:
$197.43M
Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial h...[Read more]
Industry
Biotechnology
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
TENX
According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.52. This represents a change of -32.92% compared to the average of 21.64 of the last 4 quarters.
The mean historical Current Ratio of Tenax Therapeutics, Inc. over the last ten years is 6.81. The current 14.52 Current Ratio has changed 21.20% with respect to the historical average. Over the past ten years (40 quarters), TENX's Current Ratio was at its highest in in the June 2025 quarter at 41.89. The Current Ratio was at its lowest in in the September 2016 quarter at 1.52.
Average
6.81
Median
3.45
Minimum
1.74
Maximum
20.60
Discovering the peaks and valleys of Tenax Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 532.43%
Maximum Annual Current Ratio = 20.60
Minimum Annual Increase = -71.31%
Minimum Annual Current Ratio = 1.74
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 14.56 | -29.30% |
| 2024 | 20.60 | 532.43% |
| 2023 | 3.26 | 87.61% |
| 2022 | 1.74 | -52.26% |
| 2021 | 3.64 | 13.42% |
| 2020 | 3.21 | 31.40% |
| 2019 | 2.44 | -71.31% |
| 2018 | 8.51 | 6.45% |
| 2017 | 7.99 | 263.55% |
| 2016 | 2.20 | -50.80% |
The current Current Ratio of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.81
5-year avg
8.76
10-year avg
6.81
Tenax Therapeutics, Inc.’s Current Ratio is greater than Verrica Pharmaceuticals Inc. (2.02), greater than SAB Biotherapeutics, Inc. (11.45), greater than Q32 Bio Inc. (5.36), less than AN2 Therapeutics, Inc. (15.73), greater than Jasper Therapeutics, Inc. (2.26), greater than NextCure, Inc. (4.61), greater than Plus Therapeutics, Inc. (2.27), greater than Boundless Bio, Inc. (9.87), greater than Pluri Inc. (0.33), less than Minerva Neurosciences, Inc. (17.65),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.02 | $61.03M | |
| 11.45 | $31.83M | |
| 5.36 | $161.49M | |
| 15.73 | $129.89M | |
| 2.26 | $7.44M | |
| 4.61 | $5.56M | |
| 2.27 | $12.12M | |
| 9.87 | $31.67M | |
| 0.33 | $20.41M | |
| 17.65 | $31.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tenax Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tenax Therapeutics, Inc. (TENX)?
What is the highest Current Ratio for Tenax Therapeutics, Inc. (TENX)?
What is the 3-year average Current Ratio for Tenax Therapeutics, Inc. (TENX)?
What is the 5-year average Current Ratio for Tenax Therapeutics, Inc. (TENX)?
How does the current Current Ratio for Tenax Therapeutics, Inc. (TENX) compare to its historical average?